UK markets open in 3 hours 47 minutes

Apontis Pharma AG (APPH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
10.90-0.05 (-0.46%)
At close: 03:26PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 96.05M
Enterprise value 66.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.88
Price/book (mrq)2.36
Enterprise value/revenue 1.29
Enterprise value/EBITDA 27.58

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-54.37%
S&P500 52-week change 3-2.99%
52-week high 327.30
52-week low 310.40
50-day moving average 311.37
200-day moving average 314.93

Share statistics

Avg vol (3-month) 3124
Avg vol (10-day) 361
Shares outstanding 58.5M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 10.00%
% held by institutions 133.18%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin -1.46%
Operating margin (ttm)5.98%

Management effectiveness

Return on assets (ttm)4.57%
Return on equity (ttm)-3.37%

Income statement

Revenue (ttm)51.18M
Revenue per share (ttm)6.02
Quarterly revenue growth (yoy)25.90%
Gross profit (ttm)33.79M
EBITDA 3.09M
Net income avi to common (ttm)-745.24k
Diluted EPS (ttm)-0.09
Quarterly earnings growth (yoy)88.10%

Balance sheet

Total cash (mrq)29.84M
Total cash per share (mrq)3.51
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.79
Book value per share (mrq)4.79

Cash flow statement

Operating cash flow (ttm)3.43M
Levered free cash flow (ttm)-582.64k